As Markets Evolve, ABI Shifts Focus to Mining New Revenues in Consumables | GenomeWeb

For Applied Biosystems, the first question typically asked when a customer signs on the dotted line after buying an expensive instrument is likely the most important one.

"Can we supply you with the chemistry, the chips, the software, and, by the way, can we have our folks take care of all of that for you?" is the molecular biology toolmaker's equivalent of fast food's "You want fries with that?" But it is much more than an upsell.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.